Woodline Partners LP

Position in EDIT — Editas Medicine, Inc.

CIK 1784547 San Francisco, CA

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,519,810

+$9,657,733 QoQ

Shares Held

3,555,497

+320.1% QoQ

Ownership

2.32%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#10

of 216 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. EDIT ranks #88 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,519,810	3,555,497	+320.1%	Shares	Sole	2026-08-14
2025-06-30	$1,862,077	846,399	+1.0%	Shares	Sole	2025-08-14
2024-12-31	$1,064,792	838,419	-6.9%	Shares	Sole	2025-02-14
2024-09-30	$3,070,435	900,421	-7.2%	Shares	Sole	2024-11-14
2024-06-30	$4,532,192	970,491	+8.4%	Shares	Sole	2024-08-14
2024-03-31	$6,640,900	895,000	-0.0%	Shares	Sole	2024-05-15
2023-12-31	$9,070,412	895,401	-72.5%	Shares	Sole	2024-02-14
2023-09-30	$25,425,738	3,259,710	+18.6%	Shares	Sole	2023-11-14
2023-06-30	$22,626,780	2,749,305	+3.9%	Shares	Sole	2023-08-14
2023-03-31	$19,187,995	2,646,620	+27.3%	Shares	Sole	2023-05-15
2022-12-31	$18,438,494	2,078,748	+104.4%	Shares	Sole	2023-02-14
2022-06-30	$12,029,820	1,016,891	+4346.2%	Shares	Sole	2022-08-15
2022-03-31	$435,006	22,871	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.